By contrast, type 2 mutations,which are mostly missense changes that reduce pVHL activity, predispose to theentire VHL spectrum, including pheochromocytomas with or without RCC, calledtype 2B and type 2A, respectively [6]. The gene discussed is VHL; the disease is renal cell carcinoma.